120 pending office actions • 56 clients
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19333867 | Untitled | Croivalve Ltd. | HOBAN, MELISSA A | 3774 | Non-Final OA | |
| 18775485 | Untitled | Belgravia Wood Limited | IJAZ, MUHAMMAD | 3631 | Non-Final OA | |
| 19407845 | Untitled | Suzhou Inhal Pharma Co., Ltd. | GHALI, ISIS A D | 1611 | Non-Final OA | |
| 19411693 | Untitled | Brightheart SAS | YANG, WEI WEN | 2662 | Non-Final OA | |
| 19263093 | ELECTRIC LIGHTING SYSTEMS WITH REMOVABLY COUPLABLE POWER DEVICES | Belgravia Wood Limited | SONG, ZHENG B | 2875 | Non-Final OA | Jul 08, 2025 |
| 19255499 | TREATMENT OF HR+/HER2- BREAST CANCER USING SACITUZUMAB GOVITECAN | Gilead Sciences, Inc. | PUTTLITZ, KARL J | 1646 | Non-Final OA | Jun 30, 2025 |
| 19224643 | METHODS, APPARATUSES, AND SYSTEMS FOR THE TREATMENT OF PULMONARY DISORDERS | Galvanize Therapeutics, Inc. | ZINK, AMANDA L | 3794 | Non-Final OA | May 30, 2025 |
| 19218869 | WIRELESSLY POWERED DECORATIVE SYSTEMS AND DEVICES | Belgravia Wood Limited | TRUONG, BAO Q | 2875 | Non-Final OA | May 27, 2025 |
| 19094775 | PESTICIDAL DEVICE AND DELIVERY METHOD THEREOF | Ross Lifescience Usa Inc. | SCHMID, BROOK VICTORIA | 3642 | Non-Final OA | Mar 28, 2025 |
| 19013992 | PHOTOVOLTAIC TRACKING SUPPORT AND TRANSMISSION DEVICE THEREOF | Mokun Renewable Technologies Co., Ltd. | MERSHON, JAYNE L | 1721 | Non-Final OA | Jan 08, 2025 |
| 19009543 | INFLATABLE PILLOW | Ballast Outdoor Gear, Ll. | KURILLA, ERIC J | 3619 | Non-Final OA | Jan 03, 2025 |
| 18864825 | CONNECTING ASSEMBLY AND PHOTOVOLTAIC BRACKET | Mokun Renewable Technologies Co., Ltd. | KRYCINSKI, STANTON L | 3631 | Non-Final OA | Nov 11, 2024 |
| 18863978 | PHOTOVOLTAIC SUPPORT | Mokun Renewable Technologies Co., Ltd. | MARSH, STEVEN M | 3632 | Non-Final OA | Nov 07, 2024 |
| 18924544 | ARTIFICIAL TREES WITH WIRELESS POWER TRANSMISSION | Belgravia Wood Limited | TRUONG, BAO Q | 2875 | Final Rejection | Oct 23, 2024 |
| 18920601 | HEART VALVE PROSTHESIS DELIVERY SYSTEM AND METHOD FOR DELIVERY OF HEART VALVE PROSTHESIS WITH INTRODUCER SHEATH | Jenavalve Technology, Inc. | LONG, SARAH A | 3771 | Non-Final OA | Oct 18, 2024 |
| 18917836 | EFFECTOR CELLS AND USE THEREOF FOR ALLOGENEIC ADOPTIVE CELL THERAPIES IN SOLID TUMORS | Fate Therapeutics, Inc. | FAUST, AMBER KATHLEEN | 1643 | Non-Final OA | Oct 16, 2024 |
| 18856048 | INTELLIGENT ROBOTIC COMANIPULATION ASSISTANT FOR SURGERY | Moon Surgical SAS | CAREY, MICHAEL JAMES | 3795 | Non-Final OA | Oct 10, 2024 |
| 18894166 | IN-LINE TRANSMISSION CONTROL PROTOCOL PROCESSING ENGINE USING A SYSTOLIC ARRAY | Secturion Systems, Inc. | HUQ, FARZANA B | 2455 | Non-Final OA | Sep 24, 2024 |
| 18893766 | SYSTEM AND METHOD FOR CONTROLLING DECORATIVE LIGHTING | Belgravia Wood Limited | TRAN, ANH Q | 2844 | Non-Final OA | Sep 23, 2024 |
| 18828987 | VARIABLE MULTI-COLOR LED LIGHT STRING AND CONTROLLER FOR AN ARTIFICIAL TREE | Belgravia Wood Limited | CRAWFORD, JASON | 2844 | Non-Final OA | Sep 09, 2024 |
| 18805400 | SYSTEMS AND METHODS FOR TISSUE ABLATION AND MEASUREMENTS RELATING TO THE SAME | Hepta Medical SAS | ZIEGLER, ABIGAIL M | 3794 | Non-Final OA | Aug 14, 2024 |
| 18776231 | CATHETER WITH LUBRICIOUS COATING FOR DISTAL ACCESS TO THE VASCULATURE INCLUDING THE NEUROVASCULATURE | Julier Medical SAS | NEMER, OSAMA MOHAMMAD | 3771 | Non-Final OA | Jul 17, 2024 |
| 18676020 | IMPLANTABLE PUMP SYSTEM HAVING AN UNDULATING MEMBRANE | Corwave SA | TEJANI, ANKIT D | 3796 | Non-Final OA | May 28, 2024 |
| 18645220 | METHODS, APPARATUSES, AND SYSTEMS FOR THE TREATMENT OF DISEASE STATES AND DISORDERS | Galvanize Therapeutics, Inc. | VOORHEES, CATHERINE M | 3792 | Non-Final OA | Apr 24, 2024 |
| 18701533 | ALDEHYDE DEHYDROGENASE VARIANTS AND METHODS OF USE | Genomatica, Inc. | DAVIS, RUTH A | 1699 | Non-Final OA | Apr 15, 2024 |
| 18589079 | ELECTRO-STIMULATION SYSTEMS AND METHODS FOR REHABILITATION AND TREATMENT OF PELVIC DISORDERS | Comphya SA | FAIRCHILD, MALLIKA DIPAYAN | 3792 | Non-Final OA | Feb 27, 2024 |
| 18581371 | NON-SURGICAL LASER TREATMENT FOR A FIBROUS MASS | Unknown | BERTRAM, ERIC D | 3796 | Non-Final OA | Feb 19, 2024 |
| 18442958 | SYSTEMS AND METHODS FOR MANAGEMENT OF VIRTUAL AGENTS | Interwoven Worlds Inc. | BLAISE, MALINA D | 3715 | Non-Final OA | Feb 15, 2024 |
| 18417800 | METHODS FOR ANALYSIS OF CELL-FREE NUCLEIC ACIDS IN URINE | Grail, Inc. | GIAMMONA, FRANCESCA FILIPPA | 1681 | Non-Final OA | Jan 19, 2024 |
| 18416809 | CONTROLLED LESION AND IMMUNE RESPONSE TO PULSED ELECTRIC FIELD THERAPY | Galvanize Therapeutics , Inc. | FOWLER, DANIEL WAYNE | 3794 | Non-Final OA | Jan 18, 2024 |
| 18580585 | FORMATE DEHYDROGENASE VARIANTS AND METHODS OF USE | Genomatica, Inc. | SINGH, SATYENDRA K | 1657 | Non-Final OA | Jan 18, 2024 |
| 18416505 | DEVICES, SYSTEMS AND METHODS FOR THE TREATMENT OF ABNORMAL TISSUE | Galvanize Therapeutics, Inc. | BLAISE, BRADFORD CHRISTOPHER | 3794 | Non-Final OA | Jan 18, 2024 |
| 18408651 | TISSUE ANCHORING DEVICE | Endoron Medical Ltd. | RODJOM, KATHERINE MARIE | 3771 | Final Rejection | Jan 10, 2024 |
| 18406611 | DATA SECURITY FOR PORTABLE STORAGE MEDIUMS | Secturion Systems, Inc. | BINCZAK, BRANDON MICHAEL | 2437 | Final Rejection | Jan 08, 2024 |
| 18393023 | PROGRAMMABLE NUCLEASE DIAGNOSTIC DEVICE | Mammoth Biosciences, Inc. | TURPIN, ZACHARY MARK | 1682 | Non-Final OA | Dec 21, 2023 |
| 18538995 | TISSUE-SPECIFIC METHYLATION MARKER | Grail, Inc. | SITTON, JEHANNE SOUAYA | 1682 | Final Rejection | Dec 13, 2023 |
| 18533642 | APPLYING PULSED ELECTRIC FIELDS IN THE TREATMENT OF THE VASCULATURE | Galvanize Therapeutics, Inc. | GOOD, SAMANTHA M | 3794 | Non-Final OA | Dec 08, 2023 |
| 18518253 | CATHETER SYSTEM FOR SEQUENTIAL DEPLOYMENT OF AN EXPANDABLE IMPLANT | Jenavalve Technology, Inc. | STEWART, ALVIN J | 3799 | Non-Final OA | Nov 22, 2023 |
| 18506918 | ENHANCED GUIDE NUCLEIC ACIDS AND METHODS OF USE | Mammoth Biosciences, Inc. | YU, TIAN NMN | 1681 | Non-Final OA | Nov 10, 2023 |
| 18559756 | COMBINATION OF A TLR8 MODULATING COMPOUND AND ANTI-HBV siRNA THERAPEUTICS | VIR BIOTECHNOLOGY, INC. | MEYERING, SHABANA SHABBEER | 1635 | Non-Final OA | Nov 08, 2023 |
| 18501627 | COMPOSITION AND METHODS FOR INDUCING MYELOID SUPPRESSIVE CELLS AND USE THEREOF | Fate Therapeutics, Inc. | O'NEILL, MARISOL ANN | 1633 | Non-Final OA | Nov 03, 2023 |
| 18500032 | Method for Treating Blood Cancers | Lantern Pharma Inc. | BARSKY, JARED | 1628 | Non-Final OA | Nov 01, 2023 |
| 18482834 | MICROORGANISMS AND METHODS FOR PRODUCING (3R)-HYDROXYBUTYL (3R)-HYDROXYBUTYRATE | Genomatica, Inc. | LANKFORD JR, LEON B | 1657 | Non-Final OA | Oct 06, 2023 |
| 18554448 | PHOSPHOKETOLASE VARIANTS AND METHODS OF USE | Genomatica, Inc. | BERKE-SCHLESSEL, DAVID W | 1651 | Non-Final OA | Oct 06, 2023 |
| 18481182 | PROGRAMMABLE NUCLEASES AND METHODS OF USE | Mammoth Biosciences, Inc. | VYAS, KEYUR ANILKUMAR | 1637 | Non-Final OA | Oct 04, 2023 |
| 18480382 | SYSTEMS AND METHODS FOR USB SWITCHING IN A COLLABORATION SYSTEM | Screenbeam Inc. | YU, HENRY W | 2181 | Final Rejection | Oct 03, 2023 |
| 18372280 | DATA STREAM PROTOCOL FIELD DECODING BY A SYSTOLIC ARRAY | Secturion Systems, Inc. | HUISMAN, DAVID J | 2183 | Non-Final OA | Sep 25, 2023 |
| 18469170 | PROCESS AND SYSTEMS FOR OBTAINING 1,3-BUTANEDIOL FROM FERMENTATION BROTHS | Genomatica, Inc. | MURESAN, ANA Z | 1692 | Final Rejection | Sep 18, 2023 |
| 18469512 | EFFECTOR PROTEINS, EFFECTOR PARTNERS, COMPOSITIONS, SYSTEMS AND METHODS OF USE THEREOF | Mammoth Biosciences, Inc. | HIBBERT, CATHERINE S | 1658 | Non-Final OA | Sep 18, 2023 |
| 18461239 | SYSTEMS AND METHODS FOR DEPLOYING PHOTOVOLTAIC MODULES | Mokun Solar Technology Inc. | CANNON, RYAN SMITH | 1726 | Final Rejection | Sep 05, 2023 |
| 18241603 | MULTI-TENANCY ARCHITECTURE | Secturion Systems, Inc. | JAMSHIDI, GHODRAT | 2493 | Non-Final OA | Sep 01, 2023 |
| 18264753 | ELECTRO-STIMULATION SYSTEMS AND METHODS FOR REHABILITATION AND TREATMENT OF PELVIC DISORDERS | Comphya SA | FAIRCHILD, MALLIKA DIPAYAN | 3792 | Final Rejection | Aug 08, 2023 |
| 18364359 | PROGRAMMABLE NUCLEASES AND METHODS OF USE | Mammoth Biosciences, Inc. | KAPUSHOC, STEPHEN THOMAS | 1683 | Non-Final OA | Aug 02, 2023 |
| 18274499 | GENE THERAPY FOR NEURONAL CEROID LIPOFUSCINOSES | Tern Therapeutics, LLC | SHEN, WU CHENG WINSTON | 1682 | Non-Final OA | Jul 27, 2023 |
| 18225372 | LOCALLY-STORED REMOTE BLOCK DATA INTEGRITY | Secturion Systems, Inc. | RAHIM, MONJUR | 2436 | Final Rejection | Jul 24, 2023 |
| 18258781 | METHODS AND COMPOSITIONS FOR DIFFERENTIATING SKELETAL MUSCLE | Ixcells Biotechnologies Usa, Inc. | MATALKAH, FATIMAH KHALAF | 1638 | Non-Final OA | Jun 21, 2023 |
| 18336718 | COMPOSITIONS AND METHODS OF USING PROGRAMMABLE NUCLEASES FOR INDUCING CELL DEATH | Mammoth Biosciences, Inc. | TATGE, LEXUS MARC | 1637 | Non-Final OA | Jun 16, 2023 |
| 18334327 | METHODS AND COMPOSITIONS FOR PERFORMING A DETECTION ASSAY | Mammoth Biosciences, Inc. | VANN-OJUEKAIYE, KENDRA RAYCHELL | 1682 | Non-Final OA | Jun 13, 2023 |
| 18255553 | OFF-THE-SHELF iPSC-DERIVED NK CELL THERAPY FOR HEMATOLOGICAL CANCER TREATMENT | Fate Therapeutics, Inc. | ROONEY, NORA MAUREEN | 1641 | Non-Final OA | Jun 01, 2023 |
| 18322436 | METHODS FOR DIRECT SODIUM REMOVAL IN PATIENTS HAVING HEART FAILURE AND RENAL DYSFUNCTION | Dsrco BV | FREDRICKSON, COURTNEY B | 3783 | Final Rejection | May 23, 2023 |
| 18321240 | SYSTEMS AND METHODS PREVENTING PARAVALVULAR LEAK (PVL) ASSOCIATED WITH A REPLACEMENT STRUCTURAL CARDIAC VALVE | VALCARE MEDICAL, INC. | BLASS, PARIS MARIE | 3774 | Non-Final OA | May 22, 2023 |
| 18250733 | ENGINEERED IPSC AND PERSISTENT IMMUNE EFFECTOR CELLS | Fate Therapeutics, Inc. | SZPERKA, MICHAEL EDWARD | 1641 | Non-Final OA | Apr 26, 2023 |
| 18250737 | MULTIPLEXED ENGINEERED IPSCS AND IMMUNE EFFECTOR CELLS TARGETING SOLID TUMORS | Fate Therapeutics, Inc. | STOICA, ELLY GERALD | 1647 | Non-Final OA | Apr 26, 2023 |
| 18030613 | GENE THERAPY FOR OCULAR MANIFESTATIONS OF CLN2 DISEASE | Tern Therapeutics, LLC | THUESON, HANNA MARIE | 1638 | Non-Final OA | Apr 06, 2023 |
| 18131105 | Devices and Methods for Improving the Longevity of a Wig Installation | Ave Enterprise Group | STEITZ, RACHEL RUNNING | 3772 | Non-Final OA | Apr 05, 2023 |
| 18296296 | ENGINEERED CD200R ANTIBODIES AND USES THEREOF | Gilead Sciences, Inc. | HOWARD, ZACHARY C | 1674 | Non-Final OA | Apr 05, 2023 |
| 18194151 | Pregnancy clock proteins for predicting due date and time to birth | Sera Prognostics, Inc. | COUNTS, GARY W | 1678 | Final Rejection | Mar 31, 2023 |
| 18193532 | TUMESCENSE MONITORING SYSTEM FOR DIAGNOSING ERECTILE DYSFUNCTION AND METHODS OF USE | ECOLE POLYTECHNIQUE FÉDÉRALE DE LAUSANNE | COX, THADDEUS B | 3791 | Non-Final OA | Mar 30, 2023 |
| 18028457 | ENGINEERED iPSC AND ARMED IMMUNE EFFECTOR CELLS | Fate Therapeutics, Inc. | GODDARD, LAURA B | 1642 | Non-Final OA | Mar 24, 2023 |
| 18147647 | COMPOSITIONS AND METHODS FOR IDENTIFYING CELL TYPES | Grail, Inc. | KIM, YOUNG J | 1681 | Non-Final OA | Dec 28, 2022 |
| 18145440 | STABILIZING AND ADJUSTING TOOL FOR CONTROLLING A MINIMALLY INVASIVE MITRAL / TRICUSPID VALVE REPAIR SYSTEM | VALCARE MEDICAL, INC. | LOPEZ, LESLIE ANN | 3774 | Final Rejection | Dec 22, 2022 |
| 18011145 | METHYLATED DNA FRAGMENT ENRICHMENT, METHODS, COMPOSITIONS AND KITS | Grail, Inc. | SALMON, KATHERINE D | 1682 | Final Rejection | Dec 16, 2022 |
| 18001571 | UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES | Arcturus Therapeutics, Inc. | VANHORN, ABIGAIL LOUISE | 1636 | Non-Final OA | Dec 12, 2022 |
| 18001574 | UNA OLIGOMERS FOR THE TREATMENT OF POLYGLUTAMINE DISEASES | National University Corporation Tokai National Higher Education And Research System | MCLEOD, AFRICA MHAIRIE | 1635 | Non-Final OA | Dec 12, 2022 |
| 18000640 | PROGRAMMABLE NUCLEASES AND METHODS OF USE | Mammoth Biosciences, Inc. | RAVINDRA, KRISHNA NUGGEHALLI | 1636 | Non-Final OA | Dec 02, 2022 |
| 18059862 | Technical device and method for generation, recording and identification characteristic pattern in physiological and pathological data for an off-line comparison with previously collected data | Unknown | BLOCH, MICHAEL RYAN | 3791 | Final Rejection | Nov 29, 2022 |
| 18058122 | PROGRAMMABLE NUCLEASE DIAGNOSTIC DEVICE | Mammoth Biosciences, Inc. | GERHARD, ALISON CLAIRE | 1797 | Non-Final OA | Nov 22, 2022 |
| 18056410 | ENGINEERED PD-1 ANTIBODIES AND USES THEREOF | Mirobio Limited | CHATTIN, AMY MARIE | 1643 | Non-Final OA | Nov 17, 2022 |
| 18055814 | DEVICES, ASSAYS AND METHODS FOR DETECTION OF NUCLEIC ACIDS | Mammoth Biosciences, Inc. | POHNERT, STEVEN C | 1683 | Non-Final OA | Nov 15, 2022 |
| 18052505 | LIPID FORMULATIONS CONTAINING NUCLEIC ACIDS AND METHODS OF TREATMENT FOR CYSTIC FIBROSIS | Arcturus Therapeutics, Inc. | WARD, PAUL V | 1622 | Non-Final OA | Nov 03, 2022 |
| 18049258 | METHODS FOR DETECTING DISEASE USING ANALYSIS OF RNA | Grail, Inc. | ZHANG, KAIJIANG | 1684 | Non-Final OA | Oct 24, 2022 |
| 17964798 | NUCLEIC ACID CONSTRUCTS AND METHODS OF USE | Prognosys Biosciences, Inc. | GREENE, CAROLYN LEE | 1681 | Non-Final OA | Oct 12, 2022 |
| 18045270 | SYSTEMS AND METHODS FOR RENDERING CANNABIS WASTE FOR COMPOSTING | Narc Destroyer, LLC | SHERMAN, ERIC SCOTT | 1736 | Non-Final OA | Oct 10, 2022 |
| 17935042 | EFFECTOR PROTEINS AND METHODS OF USE | Mammoth Biosciences, Inc. | LIPPOLIS, ALEXANDRA ROSE | 1637 | Non-Final OA | Sep 23, 2022 |
| 17931016 | METHODS FOR ANALYSIS OF TARGET MOLECULES IN BIOLOGICAL FLUIDS | Grail, Inc. | HAQ, SHAFIQUL | 1678 | Non-Final OA | Sep 09, 2022 |
| 17930064 | IMPLANTABLE PUMP SYSTEM ENHANCEMENTS FOR USE IN CONDUCTING DIRECT SODIUM REMOVAL THERAPY | Dsrco BV | RODRIGUEZ, CRIS LOIREN | 3783 | Final Rejection | Sep 06, 2022 |
| 17900935 | DUAL-PROBE DIGITAL DROPLET PCR STRATEGY FOR SPECIFIC DETECTION OF TISSUE-SPECIFIC CIRCULATING DNA MOLECULES | Hadasit Medical Research Services & Development Ltd. | DAUNER, JOSEPH G | 1682 | Non-Final OA | Sep 01, 2022 |
| 17796553 | PROBIOTIC FORMULATION AND DELIVERY | Austrianova Singapore Pte. Ltd. | SHELLHAMMER, JAMES PAUL | 1793 | Final Rejection | Jul 29, 2022 |
| 17853716 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Fred Hutchinson Cancer Center | ZHANG, KAIJIANG | 1684 | Non-Final OA | Jun 29, 2022 |
| 17782600 | ENHANCEMENT OF iPSC-DERIVED EFFECTOR IMMUNE CELL USING SMALL COMPOUNDS | Fate Therapeutics, Inc. | WESTON, ALYSSA G | 1633 | Final Rejection | Jun 03, 2022 |
| 17749529 | MICROORGANISMS AND METHODS FOR THE PRODUCTION OF BUTADIENE USING ACETYL-COA | Genomatica, Inc. | CHOWDHURY, IQBAL HOSSAIN | 1656 | Final Rejection | May 20, 2022 |
| 17746361 | APPLYING PULSED ELECTRIC FIELDS IN THE TREATMENT OF NEURAL DISORDERS | Galvanize Therapeutics, Inc. | BLAISE, BRADFORD CHRISTOPHER | 3794 | Non-Final OA | May 17, 2022 |
| 17769651 | ENHANCED CHIMERIC ANTIGEN RECEPTOR FOR IMMUNE EFFECTOR CELL ENGINEERING AND USE THEREOF | Fate Therapeutics, Inc. | ZHU, JIANJIAN | 1631 | Non-Final OA | Apr 15, 2022 |
| 17656206 | SYSTEMS AND METHODS FOR AUTOMATED MEDICAL MONITORING AND/OR DIAGNOSIS | Unknown | ERICKSON, BENNETT S | 3683 | Non-Final OA | Mar 23, 2022 |
| 17762693 | MULTI-TARGETING EFFECTOR CELLS AND USE THEREOF | Fate Therapeutics, Inc. | MATALKAH, FATIMAH KHALAF | 1638 | Final Rejection | Mar 22, 2022 |
| 17693129 | MULTIPLEXED GENOTYPING ASSAYS WITH A SINGLE PROBE USING FLUORESCENT AMPLITUDE TUNING | Gt Molecular, LLC | HOPPE, EMMA RUTH | 1683 | Final Rejection | Mar 11, 2022 |
| 17688116 | Reagents And Methods For The Analysis of Linked Nucleic Acids | Cs Genetics Limited | ZHANG, KAIJIANG | 1684 | Non-Final OA | Mar 07, 2022 |
| 17681060 | METHODS AND SYSTEMS FOR RNA-SEQ PROFILING | Honeycomb Biotechnologies, Inc. | PARISI, JESSICA DANIELLE | 1684 | Non-Final OA | Feb 25, 2022 |
| 17591930 | REAGENTS, KITS AND METHODS FOR MOLECULAR BARCODING | Cs Genetics Limited | HAVLIN, ROBERT H | 1626 | Final Rejection | Feb 03, 2022 |
| 17629895 | COMPOSITIONS FOR DETECTION OF DNA AND METHODS OF USE THEREOF | Mammoth Biosciences, Inc. | SCHLOOP, ALLISON ELIZABETH | 1683 | Non-Final OA | Jan 25, 2022 |
| 17646858 | IMPLANTABLE PUMP HAVING INFECTION MONITORING FEATURE | Sequana Medical NV | WENG, KAI H | 3781 | Non-Final OA | Jan 03, 2022 |
| 17620526 | Reagents and Methods for the Analysis of Microparticles | Cs Genetics Limited | CHUNDURU, SURYAPRABHA | 1681 | Non-Final OA | Dec 17, 2021 |
| 17555236 | ASSAYS AND METHODS FOR DETECTION OF NUCLEIC ACIDS | Mammoth Biosciences, Inc. | WHITE, DENNIS MICHAEL | 1758 | Final Rejection | Dec 17, 2021 |
| 17438317 | CD3 RECONSTITUTION IN ENGINEERED iPSC AND IMMUNE EFFECTOR CELLS | Fate Therapeutics, Inc. | GONZALES, JOSEPHINE MARIA | 1631 | Final Rejection | Sep 10, 2021 |
| 17464341 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Fred Hutchinson Cancer Center | ZHANG, KAIJIANG | 1684 | Non-Final OA | Sep 01, 2021 |
| 17412105 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Fred Hutchinson Cancer Center | ZHANG, KAIJIANG | 1684 | Non-Final OA | Aug 25, 2021 |
| 17393609 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Grail, Inc. | DAUNER, JOSEPH G | 1682 | Final Rejection | Aug 04, 2021 |
| 17384251 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Grail, Inc. | SALMON, KATHERINE D | 1682 | Final Rejection | Jul 23, 2021 |
| 17384241 | DETECTING CANCER, CANCER TISSUE OF ORIGIN, AND/OR A CANCER CELL TYPE | Grail, Inc. | BUCHANAN, BAILEY CHEYENNE | 1682 | Final Rejection | Jul 23, 2021 |
| 17356293 | COMPOSITIONS AND METHODS FOR ACCURATELY IDENTIFYING MUTATIONS | Fred Hutchinson Cancer Center | ZHANG, KAIJIANG | 1684 | Final Rejection | Jun 23, 2021 |
| 17238060 | HEART VALVE TREATMENT DEVICE AND METHOD | The Provost, Fellows Foundation Scholars, And The Other Members Of The Board, Of The College Of The | WILLSE, DAVID H | 3774 | Final Rejection | Apr 22, 2021 |
| 17248999 | NEEDLES OF DECORATIVE ITEMS AND METHOD OF MAKING SAME | Belgravia Wood Limited | RUMMEL, JULIA L | 1784 | Non-Final OA | Feb 17, 2021 |
| 17137851 | Accessory Mount | Feradyne Outdoors, LLC | ALMATRAHI, SAHAR FARIS | 3643 | Non-Final OA | Dec 30, 2020 |
| 17254153 | Methods for the Analysis of Circulating Microparticles | Cs Genetics Limited | CHUNDURU, SURYAPRABHA | 1681 | Final Rejection | Dec 18, 2020 |
| 17040951 | ENGINEERED IMMUNE EFFECTOR CELLS AND USE THEREOF | Fate Therapeutics, Inc. | DHAR, MATASHA | 1632 | Non-Final OA | Sep 23, 2020 |
| 16919947 | BIOMARKERS AND METHODS FOR PREDICTING PREECLAMPSIA | Sera Prognostics, Inc. | BUNKER, AMY M | 1684 | Final Rejection | Jul 02, 2020 |
| 16765369 | IMMUNOTHERAPIES USING ENHANCED iPSC DERIVED EFFECTOR CELLS | Fate Therapeutics, Inc. | GAO, ASHLEY HARTMAN | 1678 | Non-Final OA | May 19, 2020 |
| 16630547 | DNA TARGETS AS TISSUE-SPECIFIC METHYLATION MARKERS | Hadasit Medical Research Services And Development Ltd. | WOOLWINE, SAMUEL C | 1681 | Final Rejection | Jan 13, 2020 |
| 15845398 | PROCESS AND SYSTEMS FOR OBTAINING 1,4-BUTANEDIOL FROM FERMENTATION BROTHS | Genomatica, Inc. | HOBSON, STEPHEN | 1776 | Non-Final OA | Dec 18, 2017 |
| 15651929 | PROCESS AND SYSTEMS FOR OBTAINING 1,4-BUTANEDIOL FROM FERMENTATION BROTHS | Genomatica, Inc. | HOBSON, STEPHEN | 1776 | Final Rejection | Jul 17, 2017 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial